BGMD

BG Medicine, Inc. BGMD

BGMD
BG Medicine, Inc. MILC
Millennium Sustainable Ventures Corp. BIMI
BIMI International Medical Inc. BNKL
Bionik Laboratories Corp. ADLI
American Medical Technologies Inc. CFRXQ
ContraFect Corporation DMKPQ
DMK Pharmaceuticals Corporation PCYS
PrimeCare Systems, Inc. IMVIF
IMV Inc. ADYX
Adynxx, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BGMD MILC BIMI BNKL ADLI CFRXQ DMKPQ PCYS IMVIF ADYX
6M 9 900.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % -90.00 % 0.00 %
YTD 0.00 % 0.00 % -52.38 % 900.00 % 0.00 % 0.00 % 0.71 % 0.00 % -90.00 % 0.00 %
1Y 0.00 % 0.00 % -88.24 % 900.00 % 0.00 % 0.00 % 907.14 % 0.00 % -90.00 % 0.00 %
3Y -75.00 % -99.95 % -99.95 % -99.98 % 0.00 % -100.00 % -99.99 % -90.00 % -100.00 % -66.67 %
5Y -99.71 % -99.96 % -100.00 % -99.99 % -99.09 % -100.00 % -100.00 % -96.67 % -100.00 % -99.92 %
10Y -99.98 % -99.98 % -100.00 % -100.00 % -94.12 % -100.00 % -100.00 % -96.67 % -100.00 % -100.00 %
From the beginning -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.99 % -100.00 % -100.00 %

Dividend

Adynxx, Inc.